These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8172347)

  • 21. [The vascular effects of estrogens and the hormonal replacement therapy of climacteric disorders].
    Shvarts GIa
    Eksp Klin Farmakol; 1996; 59(6):62-9. PubMed ID: 9181880
    [No Abstract]   [Full Text] [Related]  

  • 22. [Psychometric aspects of estrogen therapy in the climacteric. Quantification of the psychotropic effect of hormones in 122 women (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1980 Mar; 122(12):419-22. PubMed ID: 6769003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is estrogen replacement therapy necessary?
    Hammond CB; Nachtigall LE
    J Reprod Med; 1985 Oct; 30(10 Suppl):797-801. PubMed ID: 4078811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and laboratory evaluation of the preparation Synapause].
    Pilawski Z; Flizikowska G; Zółtowski M; Olszewska D; Kosmowska B; Sych Z
    Ginekol Pol; 1982; 53(11):821-6. PubMed ID: 7184808
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of progestagens in estrogen replacement therapy].
    Teter J; Potocki J
    Ginekol Pol; 1979; Suppl():286-7. PubMed ID: 548404
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral hormone therapy in pre- and postmenopause].
    Braendle W
    Med Klin (Munich); 1990 Apr; 85(4):200-5. PubMed ID: 2191210
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pro and contra hormonal substitution in the climacteric].
    Vesper B
    Gynakol Rundsch; 1988; 28 Suppl 2():175-8. PubMed ID: 3234914
    [No Abstract]   [Full Text] [Related]  

  • 29. [Principles of hormonal therapy in menopause].
    Maleeva A
    Akush Ginekol (Sofiia); 1989; 28(4):78-84. PubMed ID: 2679195
    [No Abstract]   [Full Text] [Related]  

  • 30. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost-benefit-risk analysis of estrogen treatment in the climacteric].
    Lauritzen C
    Gynakologe; 1986 Dec; 19(4):266-75. PubMed ID: 3102324
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone treatment in the climacteric].
    Siegberg R; Pekonen F
    Nord Med; 1993; 108(10):259-62. PubMed ID: 8414944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Health risks of estrogen medication?].
    Duursma SA
    Lebensversicher Med; 1987 Sep; 39(5):130-6. PubMed ID: 2890067
    [No Abstract]   [Full Text] [Related]  

  • 35. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
    Tsvetkov Ts; Tsvetkov K; Petkova U
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrogen replacement therapy: an overview.
    Brenner PF
    Int J Fertil; 1986; 31(3 Suppl [ESTROGEN]):7-14. PubMed ID: 2906341
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral hormone therapy in the pre- and postmenopausal period].
    Braendle W; Bettendorf G
    Gynakologe; 1986 Dec; 19(4):235-40. PubMed ID: 3817595
    [No Abstract]   [Full Text] [Related]  

  • 38. [New preparations for treatment of climacterial disorders].
    Nesheim BI
    Tidsskr Nor Laegeforen; 1979 May; 99(15):792-3. PubMed ID: 462446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormone therapy and the risk of cancer in the climacteric].
    Kuhl H; Taubert HD
    Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
    [No Abstract]   [Full Text] [Related]  

  • 40. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.